These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 7759859

  • 1. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 2. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 3. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul 01; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 7. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 8. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R, Wang H, Bluethmann H, Iglesias A, Wei WZ.
    Cancer Res; 1994 Mar 15; 54(6):1529-35. PubMed ID: 8137259
    [Abstract] [Full Text] [Related]

  • 9. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, Acha-Orbea H.
    Eur J Immunol; 1994 Aug 15; 24(8):1757-64. PubMed ID: 8056034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U, McLellan B, Kraus E, Huber BT.
    Cell Immunol; 1996 Mar 15; 168(2):141-7. PubMed ID: 8640859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H.
    Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418
    [Abstract] [Full Text] [Related]

  • 14. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Virology; 1996 Sep 15; 223(2):387-91. PubMed ID: 8806576
    [Abstract] [Full Text] [Related]

  • 15. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E, Scarpellino L, Lane P, Acha-Orbea H.
    Eur J Immunol; 1996 Jul 15; 26(7):1595-602. PubMed ID: 8766566
    [Abstract] [Full Text] [Related]

  • 16. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
    Wang H, Gill RF, Lichlyter D, Iglesias A, Bluethmann H, Wei WZ.
    Eur J Immunol; 1994 Dec 15; 24(12):2950-6. PubMed ID: 7805721
    [Abstract] [Full Text] [Related]

  • 17. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
    Nakano H, Yoshimoto T, Kakiuchi T, Matsuzawa A.
    Eur J Immunol; 1993 Oct 15; 23(10):2434-9. PubMed ID: 8405042
    [Abstract] [Full Text] [Related]

  • 18. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
    Nakano H, Yoshimoto T, Nariuchi H, Kakiuchi T, Matsuzawa A.
    Cell Immunol; 1996 Mar 15; 168(2):281-90. PubMed ID: 8640876
    [Abstract] [Full Text] [Related]

  • 19. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
    Kang JJ, Schwegel T, Knepper JE.
    Virology; 1993 Sep 15; 196(1):303-8. PubMed ID: 8395120
    [Abstract] [Full Text] [Related]

  • 20. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS, Todd GT, Cohen TD, Fairchild RL.
    Cell Immunol; 1995 Sep 15; 164(2):217-26. PubMed ID: 7656330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.